Regeneron/Sanofi, Amgen PCSK9 Rivalry Continues, But Not In US Courts

Federal Circuit Affirms Invalidation Of Two Amgen Patents

 
• By Mandy Jackson
businessmen moving chess pieces on board of worldwide politics
Repatha and Praluent will continue to battle for US market share • Source: Shutterstock

More from Strategy

More from Business